cyclopropane has been researched along with Dementia Praecox in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Sá, MM; Magalhães, JG; Maltarollo, VG; Primi, MC; Rangel-Yagui, CO; Trossini, GH | 1 |
| KRUSE, W | 1 |
| VOGT, AH | 1 |
| LEMERE, F | 1 |
4 other study(ies) available for cyclopropane and Dementia Praecox
| Article | Year |
|---|---|
Convergent QSAR studies on a series of NK₃ receptor antagonists for schizophrenia treatment.
Topics: Cyclopropanes; Humans; Piperidines; Quantitative Structure-Activity Relationship; Receptors, Neurokinin-3; Schizophrenia | 2016 |
Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
Topics: Cyclopropanes; Oxidoreductases; Schizophrenia; Tranquilizing Agents; Tranylcypromine; Trifluoperazine | 1960 |
The use of stelazine and parnate in chronic, withdrawn patients.
Topics: Cyclopropanes; Schizophrenia; Tranquilizing Agents; Tranylcypromine; Trifluoperazine | 1961 |
Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
Topics: Cyclopropanes; Depression; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Schizophrenia; Tranylcypromine | 1960 |